SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : View from the Center and Left
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cogito who wrote (116005)7/22/2009 10:13:22 AM
From: NAG1  Read Replies (2) of 541940
 
Allen,

I would say that drug costs are more related to the cost of doing the research on efficacy and safety rather than the cost of manufacturing. I thought I read somewhere that it takes 7-10 years to do the research to bring a drug to market and that 2 out of 3 that make it to phase 3 trials don't pan out at all and don't show efficacy. Since the exclusivity on drugs only last for 17 years, if it takes 10 years to bring a drug to market, they will need to recoup their costs and make their big profits in the next 7 years before generics can be made.

This is a big part of the costs of drugs. However, another big part is the greed of the drug companies.

Neal
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News